Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1984-11-28
|
pubmed:abstractText |
The cytotoxic action of 5-aza-2'-deoxycytidine (5-AZA-CdR) in synchronized cells and logarithmic- and plateau-phase cultures of EMT6 murine tumor cells was investigated. 5-AZA-CdR produced a greater cell kill of S phase cells than of cells in G1 phase. Cells in the logarithmic phase of growth were more sensitive to the cytotoxic effects of 5-AZA-CdR than cells in the plateau phase of growth. These results indicate that 5-AZA-CdR produces a preferential kill of cells in the S phase of the cell cycle. 5-AZA-CdR did not block the cell cycle progression of cells into S phase. The survival curve of EMT6 cells exposed to 5-AZA-CdR suggests that the cytotoxic action of this analogue is not self-limiting. The mutagenic activity of 5-AZA-CdR was investigated using induction of 6-thioguanine resistance in Chinese hamster ovary cells. 5-AZA-CdR was not a detectable mutagen in this assay system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6207950-Animals,
pubmed-meshheading:6207950-Azacitidine,
pubmed-meshheading:6207950-Cell Cycle,
pubmed-meshheading:6207950-Cell Line,
pubmed-meshheading:6207950-Cell Survival,
pubmed-meshheading:6207950-DNA Replication,
pubmed-meshheading:6207950-Female,
pubmed-meshheading:6207950-Mammary Neoplasms, Experimental,
pubmed-meshheading:6207950-Mice,
pubmed-meshheading:6207950-Mutation,
pubmed-meshheading:6207950-Thioguanine
|
pubmed:year |
1984
|
pubmed:articleTitle |
Cell cycle effects and cellular pharmacology of 5-aza-2'-deoxycytidine.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|